Advertisement

Pharmacist’s interventions to improve clinical outcomes in patients with type 2 diabetes mellitus: Nyala City, South Darfur State, Sudan

  • Ahmad Dahab Ahmad
  • Asim Ahmad Elnour
  • Mirghani AbdElrahman Yousif
  • Farah Hamad Farah
  • Hasab Alrasoul Akasha
  • Abubakar Abasaeed
  • Abdulla shehab
  • Naama Al Kalbani
  • Saif Al Nuaimim
  • Akshaya Srikanth Bhagavathula
  • Omar Abdulla Shehab
  • Abdulla AA Al Amoodi
Original Article

Abstract

Prospective randomized controlled interventional (pre and post) clinical trial aimed to examine impact of pharmacist’s interventions (during 1 year follow-up) on diabetes clinical outcomes of patients with type 2 diabetes in Nyala City, Sudan. Three hundred patients (200 intervention and 100 control groups) with type 2 diabetes were clinically evaluated for diabetes care contents before and after implementation of diabetes care international guidelines from Institute for Clinical Systems Improvement (ICSI). We measured patient’s general and diabetes satisfaction level regarding diabetes care, by using Patient Satisfaction (PSQ-18) and Diabetes Satisfaction (DSQ) Questionnaires. Diabetes care elements were compared against international guidelines to achieve target goals of blood glucose and HBA1c. The clinical pharmacist in collaboration with the diabetes care team implemented ICSI standards for care of patients with type 2 diabetes. The role of pharmacist in diabetes management team has involved behavioral and educational aspects of patients with type 2 diabetes, self-monitoring of blood glucose, lifestyle changes, and the status of diabetes care and general health. Clinically significant differences were achieved in terms of post-prandial blood glucose (PPBG) levels (7.4 ± 1.7 vs. 10.4 ± 2.0 mmol/L) between intervention and control groups, respectively. Percentage of intervention group that reached target PPBG increased from (12.0 to 54.0 %; p = 0.001). Percentage of intervention group that reached target HBA1c increased from 10.5 to 52.0 %. HBA1c values for intervention group were improved as compared to control group (7.8 ± 1.9 % vs. 9.5 ± 2 %; p = 0.001), respectively. Pharmacist’s interventions yielded increased percentage of intervention group as compared to control group, who achieved comprehensive diabetes clinical outcomes.

Keywords

Clinical diabetes outcomes Diabetes care Diabetes satisfaction Pharmacist interventions 

Notes

Acknowledgments

The authors wish to thank all participating patients, physicians, pharmacists, and nursing staff of primary health-care facilities in Nyala, South Darfur State, Sudan, for their support. We applauded the contribution: Dr. Mohammed Mandour (late former General Director of Central Medical Supplies [CMS], Khartoum, Sudan), Professor Abu Bakr Gurashi, and Professor El Hadi Mohammad (Dean Faculty of Pharmacy, University of Gezira).

Conflict of interest

Authors declare no conflict of interest.

References

  1. 1.
    International Diabetes Federation, Diabetes Atlas - 5th Edition, Brussels, 2011. www.idf.org. Accessed January 2012.Google Scholar
  2. 2.
    Ahmed AM, Ahmed NH. Hospitalization patterns of diabetic patients in Sudan. Diabetes Int. 2000;10:18–9.Google Scholar
  3. 3.
    Ahmed AM, Ahmed NH, Abdalla ME. Pattern of hospital mortality among diabetic patients in Sudan. Pract Diabetes Int. 2000;17:41–3.CrossRefGoogle Scholar
  4. 4.
    Ahmed AM. Diabetes mellitus in Sudan: size of the problem and possibilities of efficient care. Pract Diabetes Int. 2001;18:324–7.CrossRefGoogle Scholar
  5. 5.
    Elbagir M, Eltom MA. A population-based study on prevalence of diabetes in northern Sudan. Diabetes Care. 1996;24:1126–8.CrossRefGoogle Scholar
  6. 6.
    Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012;18(7):516–26.PubMedGoogle Scholar
  7. 7.
    Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718. 10.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Bolen SD, Chandar A, Falck-Ytter C, Tyler C, Perzynski AT, Gertz AM, et al. See comment in Pub Med commons below effectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regression. J Gen Intern Med. 2014;29(8):1166–76.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Al-Maskari F, El-Sadig M. Prevalence of risk factors for diabetic foot complications. BMC Fam Pract. 2008;8:59.CrossRefGoogle Scholar
  10. 10.
    Gore S. Assessing clinical trials-restricted randomization. Br Med J. 1981;282:2114–17.CrossRefGoogle Scholar
  11. 11.
    Gore SM a Altman DG, Statistics in Practice. British Medical Association, London. Ingelfinger JA, Mosteller F, Thibodeau LA and Ware JH (1994). Biostatistics in Clinical Medicine (3rd ed). (1982). McGraw Hill, New York.Google Scholar
  12. 12.
    Marshall GN and Hays RD. The Patient Satisfaction Questionnaire Short-Form (PSQ-18), P-7865. The RAND Corporation (RAND, Santa Monica, CA). (1994). Reprinted with permission.Google Scholar
  13. 13.
    Ware JE, Snyder MK, Wright WR. Development and Validation of Scales to Measure Patient Satisfaction with Medical Care Services. Vol I, Part A: Review of Literature, Overview of Methods and Results Regarding Construction of Scales. (NTIS Publication No. PB 288-329). Springfield, VA. Natl Tech Inf Serv. 1976a.Google Scholar
  14. 14.
    Ware JE, Snyder MK, Wright WR. Development and Validation of Scales to Measure Patient Satisfaction with Medical Care Services. Vol I, Part B: Results Regarding Scales Constructed from Patient Satisfaction Questionnaire and Measures of Other Health Care Perceptions. (NTIS Publication No. PB 288-329). Springfield, VA. Natl Tech Inf Serv. 1976a.Google Scholar
  15. 15.
    Michael S, Krishna D, Christine S. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis. 2013;10:1–21.Google Scholar
  16. 16.
    Piatt GA, Orchard TJ, Emerson S, Simmons D, Songer TJ, Brooks MM, et al. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care. 2006;29(4):811–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Oster RT, Virani S, Strong D, Shade S, Toth EL. Diabetes care and health status of first nations individuals with type 2 diabetes in Alberta. Can Fam Physician. 2009;Vol 55.Google Scholar
  18. 18.
    Novo A, Jokić I. Medical audit of diabetes mellitus in primary care setting in Bosnia and Herzegovina. Croat Med J. 2008;49(6):757–62.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Abdulla S, Elnour A, Abdishakur A. A clinical audit on diabetes care in patients with type 2 diabetes in Al-Ain, United Arab Emirates. Open Cardiovasc Med J. 2012;6:126–32.CrossRefGoogle Scholar
  20. 20.
    Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39(11):1828–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Sone H, Kawai K, Takagi H, Yamada N. Masashi Kobayashi (2006) outcome of one-year of specialist care of patients with type 2 diabetes: a multicenter prospective survey (JDDM2). Intern Med. 2006;45:589–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Shim YT, Lee J, Toh MP, Tang WE, Ko Y. Health-related quality of life and glycemic control in patients with type 2 diabetes mellitus in Singapore. Diabetes Medicine. 2012;29:e241–8.CrossRefGoogle Scholar
  23. 23.
    Mukherjee AK, Reddy VS, Shah S, Jhingan AK, Ramakrishnan P, Prusty V, et al. Quality of life as a key indicator of patient satisfaction and treatment compliance in people with type 2 diabetes mellitus in the IMPROVE study. J Indian Med Assoc. 2009;107:464–70.PubMedGoogle Scholar
  24. 24.
    Clifford RM, Davis WA, Batty T, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle diabetes study. Diabetes Care. 2005;28:771–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Og O‟Donovan D, Byrne S, Sahm L. The role of pharmacists in control and management of type 2 Diabetes Mellitus; a review of the literature. J Diabetol. 2011;1:5.Google Scholar
  26. 26.
    Moemen MM. Patient satisfaction among attendance of outpatient clinics of different clinical departments at alexandria main university hospital. Bullitin Alexandria Univ Fac Med. 2008; 44 No 1.Google Scholar
  27. 27.
    Sweileh WM, Aker O, Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ J Res. (Najah Sciences). 2005; Vol. 19.Google Scholar
  28. 28.
    Testa M. Improving diabetes therapy: improving satisfaction. Diabetes Voice. 2003;48(4):23–5.Google Scholar
  29. 29.
    Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res. 2009;18(1):99–107.CrossRefPubMedGoogle Scholar
  30. 30.
    Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Tikinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM Version II) among outpatient pharmacy consumers. Value Health. 2005;8 Suppl 1:S9–S24.Google Scholar
  32. 32.
    Brod M, Valensi P, Shaban JA, Bushnell DM, Christensen TL. b) Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors. Qual Life Res. 2010;19(9):1285–93.PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, et al. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patient with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009;19(1):45–53.CrossRefPubMedGoogle Scholar
  34. 34.
    Williams SA, Pollack MF, Bonaventura DM. Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;91(3):363–70.CrossRefPubMedGoogle Scholar
  35. 35.
    Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence, treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract. 2010;87(2):204–10.CrossRefPubMedGoogle Scholar
  36. 36.
    Biderman A, Noff E, Harris S, Friedman N, Levy A. Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract. 2009;26(2):102–8.CrossRefPubMedGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2015

Authors and Affiliations

  • Ahmad Dahab Ahmad
    • 1
    • 2
  • Asim Ahmad Elnour
    • 3
  • Mirghani AbdElrahman Yousif
    • 4
  • Farah Hamad Farah
    • 5
  • Hasab Alrasoul Akasha
    • 6
  • Abubakar Abasaeed
    • 7
    • 8
  • Abdulla shehab
    • 9
  • Naama Al Kalbani
    • 10
  • Saif Al Nuaimim
    • 10
  • Akshaya Srikanth Bhagavathula
    • 11
  • Omar Abdulla Shehab
    • 9
  • Abdulla AA Al Amoodi
    • 9
  1. 1.Revolving Drug Fund (RDF), Ministry of Health (MOH)NyalaSudan
  2. 2.Department of Pharmaceutics, Faculty of PharmacyGezira UniversityMedaniSudan
  3. 3.Department of Pharmacology, College of medicine and health SciencesUAE UniversityAl AinUAE
  4. 4.Department of Clinical Pharmacy, College of PharmacyTaif UniversityTaifSaudi Arabia
  5. 5.College of Pharmacy and health SciencesAjman University of Sciences and TechnologyAjmanUAE
  6. 6.The Epidemiological Laboratory (Epi-Lab)KhartoumSudan
  7. 7.Social and Clinical Pharmacy Department, Faculty of PharmacyCharles UniversityHradec KraloveCzech Republic
  8. 8.Registration and Drug Control DepartmentMinistry of HealthAbu DhabiUAE
  9. 9.Department of Internal Medicine, College of Medicine and Health SciencesUAE UniversityAl AinUAE
  10. 10.Abu Dhabi Health Services-SEHATawam HospitalAl AinUAE
  11. 11.Department of Clinical PharmacyUniversity of Gondar-College of Medicine and Health SciencesGondarEthiopia

Personalised recommendations